Cargando…
Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease
Ischemic heart disease (IHD), especially myocardial infarction (MI), is a leading cause of death worldwide. Although coronary reperfusion is the most straightforward treatment for limiting the MI size, it has nevertheless been shown to exacerbate ischemic myocardial injury. Therefore, identifying an...
Autor principal: | Messadi, Erij |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605524/ https://www.ncbi.nlm.nih.gov/pubmed/37892221 http://dx.doi.org/10.3390/biom13101539 |
Ejemplares similares
-
Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion
por: Tourki, Bochra, et al.
Publicado: (2016) -
Lebetin 2, a Snake Venom-Derived B-Type Natriuretic Peptide, Provides Immediate and Prolonged Protection against Myocardial Ischemia-Reperfusion Injury via Modulation of Post-Ischemic Inflammatory Response
por: Tourki, Bochra, et al.
Publicado: (2019) -
Snake Venom in Therapeutics
Publicado: (1937) -
Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases
por: Frangieh, Jacinthe, et al.
Publicado: (2021) -
Perspective on the Therapeutics of Anti-Snake Venom
por: Gómez-Betancur, Isabel, et al.
Publicado: (2019)